Archives

by in
Entry Author Date Location
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return 02/27/13 Boston
Frazier Makes It Official: Seeking to Raise New $400M Fund 07/03/12 Seattle
Frazier Healthcare Aims for First Biotech VC Fund After Financial Crisis 01/19/12 Seattle
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Allena Pharma Launches With $15M From Third Rock and Other Top-Tier VCs 11/16/11 Boston
Philanthropist John Flatley Starts Venture Group to Back New Cystic Fibrosis Treatments 01/27/11 Boston
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News 01/21/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
Liprotamase Drug Slowed by FDA Panel 01/14/11 Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund 01/06/11 Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News 01/05/11 Boston
Longwood Raises $85M First Fund 01/03/11 Boston
Eli Lilly Pays up to $380M for Alnara Pharma 07/20/10 Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal 07/08/10 Boston
Google Pays $700M for ITA, Eli Lilly Buys Alnara, Skyhook Lands Samsung Partnership, & More Boston-Area Deals News 07/07/10 Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug 07/02/10 Boston
Eli Lilly & Co. Acquires Alnara Pharmaceuticals for Undisclosed Sum 07/02/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Sirtris Vet Michelle Dipp Takes Over Key Role at Glaxo as Westphal Returns to VC 04/22/10 Boston
Healthcare Dominates Massachusetts’ Top 10 Deals 04/22/10 Boston
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News 04/16/10 Boston
Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston 04/12/10 Boston
Prominent Flatley Family Launches Boston Nonprofit for Cystic Fibrosis Drug Research 03/03/10 Boston
$140M for New MPM BioVentures Fund 02/12/10 Boston
Happy 2010: Bay State Startups Ring in the New Year with $355M in January Venture Funding 02/11/10 Boston
Alnara Adds $35M, Harvest Power Teams Up with Waste Management, & More Boston-Area Deals News 01/29/10 Boston
Alnara Bags $35M B Round, Plans to Seek FDA Approval for Cystic Fibrosis Drug 01/28/10 Boston
Alnara Pharmaceuticals Lands $35,000,000 Series B Funding Round 01/28/10 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.